HOME >> BIOLOGY >> NEWS
Yale technology spins out varicose vein device company: Vascular Insights, LLC

New Haven, Conn. -- A new company, Vascular Insights, LLC, was founded to develop, manufacture and market devices to treat varicose vein disease, based on technology invented by Michael Tal, M.D., assistant professor of diagnostic radiology and director of research interventional radiology at Yale University School of Medicine.

"While varicose vein disease is normally not a life threatening condition, it can cause severe leg discomfort and serious complications, including clotting, leg edema, skin ulceration and thrombophlebitis," said Tal. "However, a universal problem caused by the condition is unsightliness of the bulging veins."

Vascular Insights is developing a simplified procedure using a single, disposable product for elimination of varicose veins. Among the procedure's advantages, the company believes it will eliminate the need for anesthesia, hospitalization or surgery, and cause less damage to surrounding tissue and nerves. This would translate into considerably reduced convalescence, complications and pain for patients. Varicose veins, including sapheno-femoral reflux disease, affect between 75 and 150 million people in North America and Western Europe. The condition involves major blood vessels of the leg, and is different than "spider veins," which affects the minor blood vessels.

Traditional therapy for varicose veins is surgery, but worldwide only an estimated one million people undergo the extensive surgical stripping and ligation operations each year at a cost of as much as between $2,500 and $5,000 per leg.

"The simplicity of the Vascular Insights approach represents an attractive new treatment option for the present one million annual procedures and the 30 to 50 million varicose vein sufferers in the US who currently do not seek treatment," said John Marano,
'"/>

Contact: Janet Rettig Emanuel
janet.emanuel@yale.edu
203-432-2157
Yale University
5-Apr-2006


Page: 1 2

Related biology news :

1. AFCYBER holds science and technology symposium
2. New technology reveals seal behavior
3. Nanotechnology helps scientists make bendy sensors for hydrogen vehicles
4. FDA Nanotechnology Task Force takes positive step forward
5. Liverpool amongst first in UK to install unique DNA sequencing technology
6. EPA foregoes opportunity to improve nanotechnology oversight
7. The Cancer Genome Atlas awards funds for technology development
8. Autism theory put to the test with new technology
9. Nanotechnology, medicine and bioethics
10. Nanotechnology: consumers must be convinced benefits outweigh risks
11. Stem cell licensing deal positions Toronto as world leader in technology

Post Your Comments:
(Date:6/18/2013)... -- Paris Air Show – Marvin Test Solutions ... leading provider of innovative test solutions for military ... this week at the Paris Air Show ... increasingly complex armament systems with longer lifecycles, industry ... solutions that address legacy system obsolescence. Marvin Test ...
(Date:6/18/2013)... Calgary,s Faculty of Medicine have discovered a mechanism that ... Platelets, a component of blood typically associated with clotting, ... upon detection, seal it off from the rest of ... Nature Immunology this week, provide the science community ... community has known that platelets do participate in immunity, ...
(Date:6/18/2013)... Department,s National Renewable Energy Laboratory (NREL), and the ... describing a novel cellulose-degrading enzyme from a marine ... as the gribble. , Gribbles are biologically ... to produce their own enzymes instead of using ... eat. New biomass-degrading enzymes from novel sources such ...
Breaking Biology News(10 mins):Marvin Test Solutions Demonstrates Next-Generation Armament Test Solutions at Paris Air Show 2Marvin Test Solutions Demonstrates Next-Generation Armament Test Solutions at Paris Air Show 3Immunity mechanism discovered 2Novel enzyme from tiny gribble could prove a boon for biofuels research 2
(Date:6/19/2013)... June 19, 2013 BioConvergence team ... speaking faculty at 2013’s BioLogistics Summit in San ... coordinated by Cold Chain IQ and IQPC, addressed ... “complexity” is, in part, attributed to current trends ... “Implicit within these trends is an increase in ...
(Date:6/19/2013)... Toronto, Canada (PRWEB) June 19, 2013 ... clinical trial business can potentially be worth up ... With this opportunity, the Indian government is taking ... clinical trials the process. , This presentation will ... clinical trial regulations ,     Immediate and long ...
(Date:6/19/2013)... TX (PRWEB) June 19, 2013 Applied ... application report that details the measurement of sulfur in ... NEX QC+ high resolution benchtop EDXRF analyzer . The ... standard test method ISO 13032. This International Standard ... for the determination of sulfur content in automotive gasoline. ...
(Date:6/19/2013)... Bellingham, Washington (PRWEB) June 18, 2013 ... on complex materials, costs and other trends will highlight ... in Monterey, California this fall. In its 33rd year, ... and includes an exhibition of key suppliers, approximately 100 ... by SPIE, the international society for optics and ...
Breaking Biology Technology:BioConvergence® Presents at BioLogistics Summit on Risk Matrix for Biosamples during Shipment 2Rigaku Publishes New Application Note for Analysis of ULSD Per ISO 13032 2‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 2‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 3
Cached News: